← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
HomeStocksAMRZAnalysis
OverviewAnalysisPriceRevenueEarningsP/ERatiosDividendTargets
Analysis OverviewBuyUpdated May 1, 2026

AMRZ logoAmrize Ltd (AMRZ) Stock Analysis

Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.

Analyst consensus
Buy
Covering
7
analysts
5 bullish · 0 bearish · 7 covering AMRZ
Strong Buy
0
Buy
5
Hold
2
Sell
0
Strong Sell
0
Consensus Target
$66
+23.9% vs today
Scenario Range
— – —
Model bear to bull value window
Coverage
7
Published analyst ratings
Valuation Context
19.0x
Forward P/E · Market cap $30.3B

Decision Summary

Amrize Ltd (AMRZ) is rated Buy by Wall Street. 5 of 7 analysts are bullish, with a consensus target of $66 versus a current price of $53.37. That implies +23.9% upside, while the model valuation range spans — to —.

Note: Strong analyst support doesn't guarantee returns. At 19.0x forward earnings, much of the optimism may already be priced in. Use the scenario range to judge whether the upside justifies the risk.
Upside case
Street consensus points to +23.9% upside. The bull scenario stretches to — if AMRZ re-rates higher.
Downside frame
The bear case maps to — — a — drop — if investor confidence compresses the multiple sharply.

AMRZ price targets

Three scenarios for where AMRZ stock could go

Current
~$53
Confidence
—
Updated
May 1, 2026
Upside case

Bull case

—

The bull case requires both strong earnings delivery and the market pricing AMRZ more generously than it does today.

Market caseClosest to today

Base case

—

The base case reflects analyst consensus expectations — steady delivery without requiring a major catalyst or re-rating.

Stress case

Bear case

—

The bear case reflects a scenario where earnings shortfalls or multiple compression combine to materially reduce the stock from its current level.

Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

AMRZ logo

Amrize Ltd

AMRZ · NYSEBasic MaterialsConstruction Materials
Data as of May 1, 2026

Amrize is a building materials company that manufactures and distributes construction products across North America. It generates revenue primarily through sales of cement, aggregates, and ready-mix concrete — with cement typically representing the largest segment at around 40-50% of total revenue. The company benefits from strategic plant locations near key markets — creating a logistics cost advantage — and operates at scale in a capital-intensive industry with high barriers to entry.

Market Cap
$30.3B
Revenue TTM
$11.8B
Net Income TTM
$1.2B
Net Margin
10.3%

AMRZ Revenue and Earnings Performance

Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.

EPS Beat Rate
33%Exceptional
3 quarters tracked
Revenue Beat Rate
33%Exceptional
vs consensus estimates
Avg EPS Surprise
-12.3%
above Street consensus
Beat / Miss Record
BeatMissLeft = EPS · Right = Revenue
Q3 2025
Q4 2025
Q1 2026

Last 3 Quarters

EPS beats: 1 of 3
Q3 2025
EPS
$0.78/$1.03
-24.3%
Revenue
$3.2B/$3.4B
-5.0%
Q4 2025
EPS
$1.06/$1.02
+3.9%
Revenue
$3.7B/$3.5B
+5.4%
Q1 2026
EPS
$0.54/$0.65
-16.4%
Revenue
$2.8B/$2.9B
-2.8%
QuarterEPS (Actual / Est)EPS SurpriseRevenue (Actual / Est)Rev Surprise
Q3 2025$0.78/$1.03-24.3%$3.2B/$3.4B-5.0%
Q4 2025$1.06/$1.02+3.9%$3.7B/$3.5B+5.4%
Q1 2026$0.54/$0.65-16.4%$2.8B/$2.9B-2.8%
Next Earnings
May 19, 2026
Expected EPS
$-0.12
Expected Revenue
$2.1B

AMRZ beat EPS estimates in 1 of 3 tracked quarters. Mixed delivery makes the upcoming report a key data point for re-rating.

AMRZ Revenue Breakdown by Segment

Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.

Latest disclosure
FY 2025
Total disclosed revenue $8.5B

Product Mix

Latest annual revenue by segment or product family

Building Materials
100.0%
YoY unavailable

Tap, hover, or focus a slice to inspect segment detail.

SegmentYoYRevenueMix

Geographic Mix

Latest annual revenue by reported region

UNITED STATES
77.1%
YoY unavailable

Tap, hover, or focus a slice to inspect segment detail.

SegmentYoYRevenueMix
Building Materials is the largest disclosed segment at 100.0% of FY 2025 revenue, with no year-over-year comparison yet.
UNITED STATES is the largest reported region at 77.1%, with no year-over-year comparison yet.
See full revenue history

AMRZ Valuation Snapshot

Current multiples compared to the S&P 500, the company's sector, and its own five-year average.

Relative Value Signal
Significantly Undervalued

Fair value est. $71 — implies +32.2% from today's price.

Upside to Fair Value
32.2%
potential upside
Deep DiscountFair ValueVery Expensive
vs S&P 500 Trailing P/E
AMRZ
24.9x
vs
S&P 500
25.1x
In line with benchmark
vs Basic Materials Trailing P/E
AMRZ
24.9x
vs
Basic Materials
22.3x
+12% premium
vs AMRZ 5Y Avg P/E
Today
24.9x
vs
5Y Average
25.3x
In line with benchmark
Forward PE
19.0x
S&P 500
19.1x
-0%
Basic Materials
15.2x
+25%
5Y Avg
—
—
Trailing PE
24.9x
S&P 500
25.1x
-1%
Basic Materials
22.3x
+12%
5Y Avg
25.3x
-1%
PEG Ratio
—
S&P 500
1.72x
—
Basic Materials
1.17x
—
5Y Avg
—
—
EV/EBITDA
12.1x
S&P 500
15.2x
-20%
Basic Materials
11.0x
+11%
5Y Avg
12.0x
+1%
Price/FCF
21.3x
S&P 500
21.1x
+1%
Basic Materials
25.6x
-17%
5Y Avg
21.1x
+1%
Price/Sales
2.6x
S&P 500
3.1x
-18%
Basic Materials
1.9x
+35%
5Y Avg
2.5x
+1%
Dividend Yield
—
S&P 500
1.87%
—
Basic Materials
1.32%
—
5Y Avg
—
—
MetricAMRZS&P 500· delta vs AMRZBasic Materials5Y Avg AMRZ
Forward PE19.0x
19.1x
15.2x+25%
—
Trailing PE24.9x
25.1x
22.3x+12%
25.3x
PEG Ratio—
1.72x
1.17x
—
EV/EBITDA12.1x
15.2x-20%
11.0x+11%
12.0x
Price/FCF21.3x
21.1x
25.6x-17%
21.1x
Price/Sales2.6x
3.1x-18%
1.9x+35%
2.5x
Dividend Yield—
1.87%
1.32%
—
AMRZ trades above S&P 500 benchmarks on 0 of 5 measured multiples — appears modestly priced relative to the S&P 500 on most measures.

Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.

Open valuation tool

AMRZ Financial Health

Verdict
Strong

AMRZ generates $1.4B in free cash flow at a 12.0% margin.

Cash Engine

Revenue, margins, and cash generation

Revenue (TTM)
Trailing-twelve-month sales base
$11.8B
Revenue Growth
TTM vs prior year
—
Gross Margin
Gross profit as a share of revenue
25.7%
Operating Margin
Operating income divided by revenue
16.1%
Net Margin
Net income divided by revenue
10.3%
EPS (TTM)
Diluted earnings per share, trailing twelve months
$2.20
Free Cash Flow (TTM)
Cash generation after capex
$1.4B
FCF Margin
FCF as share of revenue — the primary cash quality signal
12.0%

Capital Quality

ROIC, leverage, and debt serviceability

ROIC
Return on invested capital — primary competitive quality signal
9.2%
ROA
Return on assets, trailing twelve months
5.0%
Cash & Equivalents
Liquid assets on the balance sheet
$1.9B
Net Debt
Total debt minus cash
$4.0B
Debt Serviceability
Net debt as a multiple of annual free cash flow
2.8× FCF

~2.8 years to full repayment at current FCF run-rate

ROE
Return on equity, trailing twelve months
9.2%

Shareholder Returns

How capital is returned to owners

Total shareholder yield
0.0%
Dividend
—
Buyback
0.0%
Share Repurchases
Trailing buyback outflow — dollar magnitude of capital returned
$0
Dividend / Share
Annualized trailing dividend per share
—
Payout Ratio
Share of earnings distributed as dividends
—
Shares Outstanding
Current diluted share count
554M

All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt).

Open full ratios page

AMRZ Stock Risk Factors

Key factors that could pressure the stock price, compress the multiple, or weigh on future results.

AI analysis · updated April 11, 2026

01
High Risk

Legal & Regulatory

Amrize faces significant legal and regulatory risk, with compliance and potential regulatory changes cited as a primary concern. Failure to meet regulatory requirements could result in fines, operational restrictions, or costly litigation, directly impacting profitability.

02
High Risk

Execution & Integration Risks

The company’s ability to maintain cement plant uptime and execute capital expenditure programs is critical. Delays or failures in plant operations, coupled with challenges integrating future mergers and acquisitions, could erode margins and strain cash flow.

03
Medium

Construction Market Fluctuations

A slowdown in the construction industry could reduce demand for Amrize’s products. Although lower interest rates and a positive growth outlook mitigate this risk, a significant downturn would still negatively affect revenue.

04
Medium

Competitive Landscape

Amrize competes with large players such as CRH, Vulcan Materials, and Cemex. Intense competition could pressure pricing, erode market share, and squeeze operating margins.

05
Medium

Operational Risks

Past cement plant outages have impacted the company, and future outages could disrupt supply chains and production. Effective maintenance and contingency planning are essential to avoid revenue loss.

These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.

Why AMRZ Stock Could Outperform

Structural drivers behind the upside case and why the stock could outperform over the next 12 months.

AI analysis · updated April 11, 2026

01

Infrastructure & Construction Boom

Backlog from data centers, energy, and infrastructure projects is expected to drive demand for Amrize's cement, aggregates, and roofing materials. The company benefits from multi‑year contracts in these sectors.

02

Diversified Building Solutions

Amrize offers a broad portfolio from cement and aggregates to roofing and wall systems, serving infrastructure, commercial, and residential construction markets. This product diversity supports stable demand across market cycles.

03

Capacity Expansion Projects

Investments in Ste. Genevieve, Malarkey in Indiana, and upgrades at St. Constant, Exshaw, and Midlothian aim to add low‑cost capacity. These projects are designed to increase production efficiency and support growth.

04

Higher Utilization & Margin Improvement

The new capacity is expected to be utilized at higher rates, which should lift EBITDA margins. Improved operational efficiency is a key catalyst for profitability.

05

Strong Revenue Growth Outlook

Amrize projects 4‑6% revenue growth for 2026, reflecting the demand momentum and capacity expansion. This growth trajectory underpins the bullish thesis.

A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.

Price target page

AMRZ Stock Price Performance

52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.

Current Price
$53.37
52W Range Position
42%
52-Week Range
Current price plotted between the 52-week low and high.
42% through range
52-Week Low
$44.12
+21.0% from the low
52-Week High
$65.94
-19.1% from the high
1 Month
-2.23%
3 Month
-4.01%
YTD
-3.7%
1 Year
+2.7%
3Y CAGR
+0.9%
5Y CAGR
+0.5%
10Y CAGR
+0.3%

Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.

Full price historyP/E history

AMRZ vs Peers

Valuation, growth, and margin comparison against the closest publicly traded peers for this company.

Peer Set
Accurate peer set
Forward PE
19.0x
vs 24.9x median
-24% below peer median
Revenue Growth
—
vs +2.6% median
Peer median unavailable
Net Margin
10.3%
vs 13.9% median
-26% below peer median
CompanyMkt CapFwd PERev GrwMarginRatingUpside
AMR
AMRZ
Amrize Ltd
$30.3B19.0x—10.3%Buy+23.9%
VMC
VMC
Vulcan Materials Company
$37.8B31.7x+5.0%13.9%Buy+12.2%
MLM
MLM
Martin Marietta Materials, Inc.
$36.6B31.0x+4.8%38.7%Buy+14.7%
EXP
EXP
Eagle Materials Inc.
$6.8B16.2x+2.6%19.4%Buy+6.9%
CRH
CRH
CRH plc
$75.2B18.9x-1.8%9.2%Buy+20.5%
FYB
FYBR
Frontier Communications Parent, Inc.
$9.6B—+0.4%-6.2%Buy-10.8%

This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.

AMRZ Dividend and Capital Return

AMRZ does not currently return meaningful capital to shareholders.

Dividend UnknownFCF Unknown
Total Shareholder Yield
0.0%
Dividend + buyback return per year
Buyback Yield
0.0%
Dividend Yield
—
Payout Ratio
—

Dividend Profile

Yield, cadence, and growth quality

Dividend / Share
Trailing annualized cash dividend
$0.44
Growth Streak
Consecutive years of dividend increases
0Y
3Y Div CAGR
—
5Y Div CAGR
—
Ex-Dividend Date
—
Payment Cadence
Annual
1 payments over the last 12 months

Buyback Engine

How much per-share support comes from repurchases

Repurchases (TTM)
Cash used for buybacks in the latest trailing period
$0
Estimated Shares Retired
0
Approx. Share Reduction
0.0%
Shares Outstanding
Current diluted share count from the screening snapshot
554M
YearDiv / ShareYoY Grw
2026$0.44—
Full dividend history
FAQ

AMRZ Investor Questions

Common questions answered from live analyst data and company financials.

6 questions
01

Is Amrize Ltd (AMRZ) stock a buy or sell in 2026?

Amrize Ltd (AMRZ) is rated Buy by Wall Street analysts as of 2026. Of 7 analysts covering the stock, 5 rate it Buy or Strong Buy, 2 rate it Hold, and 0 rate it Sell or Strong Sell. The consensus 12-month price target is $66, implying +23.9% from the current price of $53.

02

What is the AMRZ stock price target for 2026?

The Wall Street consensus price target for AMRZ is $66 based on 7 analyst estimates. The high-end target is $75 (+40.5% from today), and the low-end target is $58 (+8.7%).

03

Is Amrize Ltd (AMRZ) stock overvalued in 2026?

AMRZ trades at 19.0x times forward earnings. The stock's valuation is broadly in line with the broader market. Based on current multiples versus the peer group, the relative model signals significantly undervalued. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.

04

What are the main risks for Amrize Ltd (AMRZ) stock in 2026?

The primary risks for AMRZ in 2026 are: (1) Legal & Regulatory — Amrize faces significant legal and regulatory risk, with compliance and potential regulatory changes cited as a primary concern. (2) Execution & Integration Risks — The company’s ability to maintain cement plant uptime and execute capital expenditure programs is critical. (3) Construction Market Fluctuations — A slowdown in the construction industry could reduce demand for Amrize’s products. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.

05

When does Amrize Ltd (AMRZ) report its next earnings?

Amrize Ltd is expected to report its next earnings on approximately 2026-05-19. Consensus expects EPS of $-0.12 and revenue of $2.1B. Over recent quarters, AMRZ has beaten EPS estimates 33% of the time.

06

How much free cash flow does Amrize Ltd generate?

Amrize Ltd (AMRZ) generated $1.4B in free cash flow over the trailing twelve months — a free cash flow margin of 12.0%. AMRZ returns capital to shareholders through and share repurchases ($0 TTM).

Continue Your Research

Amrize Ltd Stock Overview

Price chart, key metrics, financial statements, and peers

AMRZ Valuation Tool

Is AMRZ cheap or expensive right now?

Compare AMRZ vs VMC

Side-by-side financials, valuation, and ratings

Deep Dive Analysis

AMRZ Price Target & Analyst RatingsAMRZ Earnings HistoryAMRZ Revenue HistoryAMRZ Price HistoryAMRZ P/E Ratio HistoryAMRZ Dividend HistoryAMRZ Financial Ratios

Related Analysis

Vulcan Materials Company (VMC) Stock AnalysisMartin Marietta Materials, Inc. (MLM) Stock AnalysisEagle Materials Inc. (EXP) Stock AnalysisCompare AMRZ vs MLMS&P 500 Mega Cap Technology Stocks
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.